Article Details
Retrieved on: 2021-05-27 15:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The meeting was called to discuss potential merits of teplizumab, which, like foralumab, is an anti-CD3 monoclonal antibody (mAb). In contrast to ...
Article found on: news.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here